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ABSTRACT
Introduction: Evaluation of antidiabetic studies was conducted on different medicinal plant products (Trigonella foenum-graecum, seeds; Syzygium 
cumini, seeds; Salavadora persica, leaves; and Terminalia chebula, seeds) on human whole blood samples. Since centuries revealed the presence of 
potent antidiabetic activity in primary and secondary metabolites of medicinal plant products.
Objective: The objective of our study is to screen these plant extracts of four different medicinal plant products on diabetic human whole blood samples.
Methods: In this study, we screened plant extracts pertaining to determine its secondary metabolites qualitatively and also analyzed its activity on 
diabetic human whole blood samples to determine total cellular content, free hemoglobin in the supernatant and also estimated its glucose content.
Results: The results of these studies claimed that these plant extracts showed antidiabetic effect at lower doses because of decline in total cellular 
content, free hemoglobin in the supernatant, and glucose content. Overall, this study claimed that all these plant extracts showed antidiabetic activity.
Conclusion: Overall, this study claimed that all these plant extracts showed antidiabetic activity.
Keywords: Trigonella foenum-graecum, Syzygium cumini, Salavadora persica, Terminalia chebula, Antidiabetic.
INTRODUCTION
Diabetes mellitus, an endocrine metabolic disorder, is one of the 
most challenging public health crises in front of the world in the 
21st century. An estimated worldwide prevalence of diabetes is 387 
million, i.e., approximately 8.3% and is expected to rise to 592 million 
by 2035 [1]. According to the recent data, the number of people with 
diabetes in India is around 62.4 million and predicted to be 87 million 
by the year 2030, making India the “Diabetes Capital” of the world [2]. 
Although diabetes is non-curable disease, it is controllable using 
various therapies such as insulin or oral antidiabetic agents. The major 
drawback of these currently available therapies is their side effects 
and prohibitive cost. Therefore, efforts are on worldwide to find more 
potent cost-effective drug with less or no side effects. Medicinal plants 
are found to have an antidiabetic property without any side effect; most 
importantly, due to their content of various secondary metabolites such 
as alkaloids, terpenoids, flavonoids, saponins, and tannins. Medicinal 
plants also possess the ability to restore the function of pancreatic 
tissues. Until now, 800 medicinal plants are reported to possess 
antidiabetic activity [3,4].
Medicinal plants, i.e., Trigonella foenum-graecum, Syzygium cumini, 
Salavadora persica, and Terminalia chebula are significant sources 
and its requirement for drug development. T. foenum graecum 
(fenugreek; family Leguminosae) [5], medicinal plant, especially 
seeds are useful in various disease therapies including tumors, 
cholesterolemic, inflammation, ulcer, nervous disorders, and dyspepsia. 
It is not only useful as a health tonic but also prevents aging, labor 
pain, and also improve mental function [6]. A lot of biochemical and 
immunopharmacological studies have already done and showed some 
medicinal properties as well, i.e., chemopreventive activity, antioxidant 
activity, anticancer activity, immunomodulatory, and gastroprotective 
activities [7]. In contrast, estrogenic activity also being reported in seed 
chloroform extract [8].
S. cumini (Jamun; family Myrtaceae) [9] is another important medicinal 
plant. Recent studies have demonstrated its several therapeutic 
roles in the treatment of diarrhea, respiratory diseases, obesity, 
hemorrhage, and allergic disorders [10]. As per the literature, out of 
four seed extracts studied, namely, the petroleum ether, chloroform 
extract, ethanol extract, and aqueous extract, it is found that ethanol 
seed extract of S. cumini Linn. (Jamun) has highest potential to 
inhibit alpha-amylase activity which is significant in the prevention 
of postprandial hyperglycemia [11]. S. persica popularly known as 
miswak belonging to family Salvadoraceae is an integral part of oral 
hygiene, especially among Muslim community. It is used as a chewing 
stick or toothpaste and as an endodontic irrigation solution in root 
canal irrigation [12]. Literature has been revealed various medicinal 
properties of S. persica including antifungal activity, antibacterial 
activity, antimicrobial activity, anti-inflammatory activity, analgesic 
activity, antihyperlipidemic and antitumor, and antibiofilm activity. 
Aqueous extract of leaves of S. persica has the ability to inhibit alpha-
amylase activity potentially [13]. A king of medicine, T. chebula Retz. 
or Haritaki belongs to family Combretaceae and has extraordinary 
power of healing; it is effectively used to cure heart diseases, bladder 
diseases, gastrointestinal, and Alzheimer’s Disease [14-16]. “Triphala,” 
a polyherbal formulation containing T. chebula, as one of its constituents 
is reported to have immunomodulatory [17] and anticancer effect [18] 
including hepatoprotective activity [19]. In an effort to search for those 
medicinal plants that are responsible for antidiabetic effect in infected 
(diabetic; higher glucose content) human whole blood samples.
METHODS
Collection of plant material
Seeds of Fenugreek and T. chebula were purchased from the local 
market of Ahmednagar, whereas S. cumini seeds and S. persica leaves 
were collected from a region of Ahmednagar, Maharashtra, India. All 
samples were authenticated by the Department of Botany, Padmashri 
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Vikhe Patil College, Pravaranagar, Loni, Rahata, Ahmednagar, 
Maharashtra, India.
Preparation of extracts
Plant materials (T. foenum graecum, S. cumini, S. persica, and T. chebula) 
were ground in a grinder. Finely ground powder was then mixed with 
organic solvents (chloroform, ethanol, and petroleum ether; Himedia), 
especially for seeds of T. foenum graecum, S. cumini, and T. chebula and 
for the leaves of S. persica (Table 1). All these extracts were subjected to 
mechanical shaking for 3 days at room temperature in an orbital shaker. 
The filtrate was next filtered through Whatman No. 41 filter paper 
and was concentrated in a rotary evaporator. For aqueous extracts 
of S. persica, the filtrate was frozen at −77°C and finally lyophilized 
at −46°C. [20].
Qualitative phytochemical estimation of metabolites
The phytochemical investigation of these medicinal plants, i.e., T. foenum 
graecum, S. cumini, S. persica, and T. chebula was studied qualitatively 
using standard methods [20] as shown in Table 2. These studies 
revealed the presence of alkaloids, saponins, and steroids in these 
medicinal plants. In addition, flavonoids, phlobatannins, terpenoids, 
coumarins, terpenoids, anthocyanins, leucoanthocyanins, and quinones 
are absent in T. foenum graecum; phlobatannins, leucoanthocyanins, 
and quinones in S. cumini; tannins, phlobatannins, terpenoids, fatty 
acids, anthocyanins, and leucoanthocyanins in S. persica, whereas 
in T. chebula, phenolics, phlobatannins, coumarins, anthocyanins, 
leucoanthocyanins, and quinones are absent.
Estimation of total cellular content and free hemoglobin content
Infected (diabetic; high glucose content; n=10) human whole blood 
samples were collected from Mangal pathology lab. Lysed human whole 
blood samples (100 µl cells containing 105 cells/well) were cultured 
in 24-well flat bottom tissue culture plate for 48 hr incubation along 
with variable doses of test material, i.e., T. foenum graecum, S. cumini, 
S. persica, and T. chebula. Huminsulin 50/50 was used as a standard 
for these studies. Performed these studies in two different set of 
experiments. In first set, centrifuge the samples at 15000 rpm after 
48 hr incubation and then collect the supernatant to determine the total 
cellular or protein content [21] using NanoDrop 1000 A280 module. In 
NanoDrop, Beer-Lambert equation (A=E*b*c) is applied and used for all 
protein calculations to correlate absorbance with concentration. In the 
second set of experiment, lysed diabetic human whole blood samples 
were treated with test material and incubate for 48 hrs and then 
washed with phosphate-buffered saline pertaining to observed the free 
hemoglobin in the supernatant. Finally, samples were analyzed through 
ultraviolet (UV) visible spectrophotometer at 570 nm [21].
Estimation of glucose content
Non-infected lysed human whole blood samples were cultured for 
48 hrs incubation along with variable doses of glucose content. After 
incubation, centrifuge the samples at 2500 rpm and estimate free 
glucose content in the supernatant. All these readings were determined 
and prepared standard curve pertaining to determine the glucose 
content in human diabetic blood samples which is determined through 
nanodrop method.
RESULTS
Estimation of total cellular content
The effect of these plant extracts on total cellular content and free 
hemoglobin content as shown in Table 3. The results of these studies 
claimed that these plant extracts showed enhancement in total cellular 
content at higher doses as compared to control. The maximum effect 
of these plant extracts at lower doses as compared to Huminsulin 
50/50.
Estimation of free hemoglobin content
In addition, similar results also observed in free hemoglobin in the 
supernatant containing plant extracts (Fig. 1). Overall, the results 
Table 1: Extraction solvent for medicinal plant products
S. No Plant name Part 
used
Extraction solvent
1 Trigonella foenum 
graecum Linn.
Seeds Chloroform extract
2 Syzygium cumini Linn. Seeds Ethanol extract
3 Salavadora persica Leaves Aqueous extract
4 Terminalia chebula Retz. Seeds Petroleum ether 
extract










Alkaloids + + + +
Phenolics + + + -
Flavonoids - + + +
Saponins + + + +
Tannins + + - +
Phlobatannins - - - -
Terpenoids - + - +
Steroids + + + +
Fatty acids + + - +
Coumarins + + -
Anthocyanins - + - -
Leucoanthocyanins - - - -
Quinones - - + -
Table 3: Effect of variable doses of medicinal plant products on 
total cellular content





Fenugreek 25 0.097±0.001*** 51.01 ↓
50 0.158±0.002** 20.20 ↓
100 0.284±0.012 43.43 ↑




25 0.059±0.001*** 70.20 ↓
50 0.147±0.001** 25.75 ↓
100 0.228±0.002 15.15 ↑




25 0.173±0.003** 12.62 ↓
50 0.189±0.003* 4.54 ↓
100 0.464±0.001 134.34 ↓




25 0.187±0.001* 5.55 ↓
50 0.258±0.001 30.30 ↑
100 0.387±0.002 95.45 ↑
200 0.434±0.004 119.19 ↑
Huminsulin 
50/50
10 0.176±0.001** 11.11 ↓
Lysed diabetic human whole blood (high glucose content) were cultured with 
variable doses of medicinal plant products. Total cellular content was measured 
after high-speed centrifugation and collect supernatant for the estimation of 
total cellular content. Values are expressed as mean±SE. The difference between 
control and variable doses of medicinal plant products is controlled by one-way 
ANOVA test (Bonferroni multiple comparison test). *p<0.05, **p<0.01, and 
***p<0.001. SE: Standard error
Statistical analysis
The difference between control and treated group of medicinal 
plant  products  is  controlled  by  one-way  ANOVA  test 
(Bonferroni  multiple  comparison  test).  *p<0.05,  **p<0.01,  and 
***p<0.001.
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claimed that these plant extracts at lower doses showed antidiabetic 
effect because of decline in free hemoglobin in the supernatant.
Estimation of glucose content
The effect of these test materials on glucose content in human whole 
blood samples as shown in Table 4. The results of these studies showed 
that these plant extracts showed decline in glucose content at lower 
doses as compared to Huminsulin 50/50.
DISCUSSION
Use of blood glucose-lowering agents is the most common strategies 
applied for the treatment of diabetes mellitus. Natural products being 
no adverse effect are the fundamental source of lead candidate that can 
prove as an effective antidiabetic agent. These natural products obtained 
from herbal preparations are easily available with lower cost [22]. 
Recently, Rashid et al., 2013, reported total 108 plant species belonging 
to 56 families with antidiabetic activity [23]. As per literature survey, 
various medicinal plants including Gynura procumbens (Lour.) Merr, 
Abies balsamea, Alnus incana, and Vaccinium vitis-idaea L. V. vitis shows 
antidiabetic properties by various mechanisms of action. Aqueous 
extract of G. procumbens shows the hypoglycemic effect by promoting 
glucose uptake by muscles cells [24]. Ethanolic extract of bark A. 
balsamea enhances insulin-stimulated glucose uptake in the skeletal 
muscle cells and adipocytes, whereas A. incana Subsp. Rugosa and V. 
vitis-idaea L. V. vitis found to inhibit glucose-6-phosphatase activity in 
hepatocytes [25].
These medicinal plant products which have the potential or its ability to 
reduce the burden of cardiovascular disease, i.e., diabetes (type 1 and 
2 diabetes). Recently, medicinal plants are the major source for drug 
development and most of the drugs that are currently available in the 
market or still under clinical trials. Actually, these drugs are derived 
directly or indirectly from medicinal plant products [21]. In this study, 
we screened its antidiabetic activity of four medicinal plant products on 
diabetic human whole blood samples.
Glycated hemoglobin (hemoglobin exposure to plasma glucose) is 
formed in a non-enzymatic glycation pathway. In general, the average 
amount of glucose content increases in diabetic person and also 
showed enhancement in the fraction of glycated hemoglobin (i.e., free 
hemoglobin in plasma) in a predictable way. In this study, treatment 
of variable doses of test candidates on diabetic human whole blood 
samples and determined total cellular content (i.e., proteins) and free 
hemoglobin in the supernatant through UV-visible spectrophotometer. 
The results showed that these test candidates declined in the total 
cellular content and free hemoglobin in the supernatant at lower 
doses as compared to Huminsulin 50/50. Overall, the results of test 
candidates showed antidiabetic activity in human whole blood samples.
CONCLUSION
These results provide evidence for the antidiabetic activities of four 
medicinal plant products. Further experimental and clinical trial 
studies are now warranted to investigate the benefit of these extracts 
for the treatment of diabetic patients.
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